Head Trauma Market – Overview
Rise in the number of trauma cases globally especially those of head trauma have prompted an increase in the demand for treatment. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry. The Head Trauma Market growth is foreseen to grow with a CAGR of 8.3% over the forecast period. The progress of the market is expected to benefit from the development of new technologies in the upcoming forecast period.
Segmental Analysis
The segmentation of the market is segmented on the basis of types, diagnosis, treatment and end users. By types, the market is segmented into haemorrhage and hematoma. By diagnosis, the market is segmented into brain scans, physical examination, and CT scan. By treatment, the market segmentation comprises of anti-seizure drugs, medical treatment, and surgery. By end users, the market is segmented into research institutes and hospitals & clinics.
Detailed Regional Analysis
The Americas region dominates the market due to the incidence of well-developed technology, growing patient population share with brain disorder, increasing health care spending, and budding government support for research & development. Additionally, intensified R&D activities and the focus of major companies are fuelling the market growth in this region. The European region has the next spot in the market due to the government support for research & development and accessibility of funds for research. This is projected to continue to drive the European market over the forecasted period. The Asia Pacific is showing the fastest growth due to the swiftly evolving healthcare technologies and high healthcare expenditure. Furthermore, the rising patient population in nations like India and South Korea are likely to fortify the market in the forecast period further. Conversely, the Middle East & Africa region controls the least stake in the market due to less accessibility of funds, inadequate medical facilities, and volatile political conditions in the African continent.
Competitive Analysis
The inventions in the products and services are the major factor in growing the market's yield and affecting the trends that are capturing attention in the market. The key success factors and players’ tendencies are regularly improving by the strategies being used by market contenders. The external factors are encouraging the market development which is dependent on the practices and the strategic roadmaps that are developed by market competitors. The significant contenders functioning in the market are GE Healthcare (U.S.), Fujifilm Holdings (Japan), Siemens Healthcare (U.S.), Shimadzu Corporation (Japan), Philips Healthcare (U.S.), Nihon Kohden Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Electrical Geodesics Inc. (U.S.), Carestream Health (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
Industry Updates:
Feb 2018 The first blood test to evaluate mild traumatic brain injury (mTBI) or concussion has been permitted to be marketed by the U.S. Food and Drug Administration. The FDA reviewed and authorized for marketing the Banyan Brain Trauma Indicator in less than six months as a portion of its Breakthrough Devices Program.
No comments:
Post a Comment